Comparison of Postoperative Pain After Application of Aloe Vera Gel Dressings With Conventional Paraffin-Based Tulle Dressings at Split-Thickness Skin Graft Donor Site

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if Aloe Vera gel dressing helps reduce pain better than traditional paraffin-based tulle dressing at the donor site of split-thickness skin grafts in adult patients aged 18 to 60. The main questions it aims to answer are: Does Aloe Vera gel dressing reduce postoperative pain more effectively than paraffin-based tulle dressing on the 7th day after surgery? Is there a difference in the need for additional pain medication between the two groups? Researchers will compare Aloe Vera gel dressing to paraffin-based tulle dressing to see if Aloe Vera leads to better pain control. Participants will: Undergo split-thickness skin graft surgery Receive either Aloe Vera gel dressing or paraffin-based tulle dressing at the donor site Have pain measured using a visual analogue scale (VAS) on the 7th day after surgery Be given pain medication if their pain score is 4 or higher, and the amount used will be recorded

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• • Patients aged 18-60 years of age of either gender needing Split thickness skin graft

Locations
Other Locations
Pakistan
Mayo Hospital Lahore
RECRUITING
Lahore
Time Frame
Start Date: 2025-08-05
Estimated Completion Date: 2026-04-14
Participants
Target number of participants: 72
Treatments
Experimental: Aloe Vera Gel Dressing
Participants in this group will receive Aloe Vera gel applied directly to the split-thickness skin graft donor site
Active_comparator: Paraffin-Based Tulle Dressing (Conventional Dressing)
Participants in this group will receive standard paraffin-based tulle dressing with chlorhexidine on the donor site.
Related Therapeutic Areas
Sponsors
Leads: King Edward Medical University

This content was sourced from clinicaltrials.gov